GHK-Cu

Overview and Mechanism of Action

GHK-Cu (copper peptide GHK-Cu, or glycyl-L-histidyl-L-lysine copper(II) complex) is a naturally occurring tripeptide-copper complex first identified in human plasma by Loren Pickart in 1973 while investigating factors in plasma that influenced liver tissue function. The tripeptide sequence glycine-histidine-lysine (GHK) exhibits high-affinity copper(II) binding through coordination of the copper ion via the glycine alpha-amino group, the histidine imidazole nitrogen, and the histidine amide nitrogen, forming a square-planar coordination complex with a dissociation constant (Kd) of approximately 10^-17 M — among the highest copper affinities measured for any biological molecule. This extraordinarily tight copper binding, combined with the tripeptide's endogenous occurrence and biological activity profile, has made GHK-Cu one of the most studied copper-containing peptides in biomedical research.

GHK-Cu concentrations in human plasma are age-dependent, averaging approximately 200 ng/mL in young adults and declining substantially with aging — a pattern that has attracted research interest in gerontological contexts. The compound is present not only in plasma but in saliva, urine, and tissue fluids, and is released from larger proteins containing the GHK sequence during proteolytic degradation following tissue injury.

The biological activities attributed to GHK-Cu span wound healing, antioxidant defense, anti-inflammatory signaling, tissue remodeling, and gene expression regulation. In the context of wound healing, GHK-Cu has been shown to attract macrophages and mast cells to wound sites, promote keratinocyte migration and proliferation, stimulate fibroblast proliferation, and enhance the synthesis of extracellular matrix components including type I and III collagens, elastin, fibronectin, and decorin. Paradoxically, it simultaneously activates matrix metalloproteinases (MMPs) that degrade damaged, cross-linked collagen, suggesting that GHK-Cu promotes an orderly remodeling cycle — removing damaged matrix while synthesizing replacement tissue — rather than simply promoting collagen deposition. This dual pro-synthesis/pro-degradation activity profile may explain the improvement in tissue quality (versus simple scar formation) reported in some wound healing models. For more on healing peptides, see our /learn/ghk-cu and /learn/bpc-157 articles.

At the molecular level, substantial research has focused on GHK-Cu's effects on gene expression. Microarray and RNA-seq studies, including work published by Pickart and colleagues, have reported that GHK-Cu modulates the expression of hundreds of genes in human fibroblasts, with affected pathways including those governing antioxidant defense (upregulation of SOD, catalase, glutathione synthetase), DNA repair, anti-inflammatory signaling, and mitochondrial function. The copper ion within the complex may participate directly in these effects through copper-dependent enzyme cofactor delivery (copper is an essential cofactor for SOD1, cytochrome c oxidase, lysyl oxidase, and other enzymes), and the peptide component may independently signal through cell surface receptors or intracellular binding partners.

Research History and Development

Following Pickart's initial 1973 isolation, GHK was subsequently identified as a tripeptide fragment of the alpha-2-macroglobulin protein and the collagen alpha chains, providing an endogenous source. Extensive research through the 1980s and 1990s characterized GHK-Cu's effects on wound healing parameters in vitro and in animal models. Studies using full-thickness excisional wound models in rodents and pigs demonstrated accelerated wound closure, improved tensile strength, and superior histological tissue organization in GHK-Cu-treated wounds compared to controls. Bone healing, hair follicle cycling, nerve regeneration, and gastric ulcer healing have also been examined in pre-clinical model systems.

The cosmetic and dermatological research application of GHK-Cu has been extensively explored, with topical formulations examined in human volunteer studies for effects on skin collagen density, wrinkle metrics, skin thickness (measured by ultrasound biomicroscopy), and photoaging markers. Published studies using profilometry, optical coherence tomography, and biopsy-based histological endpoints have reported statistically significant improvements in treated versus control skin over treatment periods of 4–12 weeks.

Typical Research Parameters

In fibroblast and keratinocyte cell culture studies, GHK-Cu is typically tested at concentrations of 1 nM to 10 μM, with endpoints including proliferation (BrdU incorporation, Ki-67 staining), migration (scratch wound assay), collagen and fibronectin gene expression (qRT-PCR), and MMP activity (zymography, fluorescent substrate assays). In in vivo wound healing studies, topical application of GHK-Cu in gel or cream vehicles has been employed in rodent and porcine full-thickness wound models, with wound area planimetry, tensile strength testing (using tensiometry on healed wounds), and histological analysis as outcome measures. Subcutaneous or intraperitoneal injection has been employed in systemic distribution studies. For research use only.

Storage Requirements

GHK-Cu in lyophilized form presents as a blue-violet powder attributable to the copper(II) complex's characteristic d-d electronic transition absorption in the visible spectrum — the blue-purple color referenced in the product designation is the expected appearance of the intact copper complex. This coloration is a useful indicator of copper coordination integrity; loss of color may indicate copper dissociation. Lyophilized powder should be stored at 2–8°C or -20°C, protected from moisture and strong light, in sealed vials. GHK-Cu is more stable than most peptides by virtue of the copper coordination, but the copper ion can catalyze oxidative reactions in the presence of hydrogen peroxide or reducing agents (Fenton-type chemistry), and strongly chelating buffers (EDTA, EGTA) will strip copper from the complex. Reconstituted aqueous solutions should be stored at 2–8°C and used within 21 days. Avoid copper-chelating compounds in assay systems.

Safety Notes and Research Considerations

GHK-Cu has an excellent documented safety profile in human cosmetic and wound healing applications, consistent with its endogenous origin and the well-characterized safety profile of copper at physiological concentrations. The copper content should be considered in experimental contexts: in cell culture, copper ions at supraphysiological concentrations are cytotoxic (IC50 values for copper cytotoxicity are well characterized for most cell lines), and GHK-Cu's copper-chelating activity may alter the effective free copper concentration in culture medium. Researchers using GHK-Cu in gene expression studies should be aware that copper itself regulates the expression of copper metabolism genes (metallothionein, ceruloplasmin, ATP7A/B), which may confound transcriptomic analyses if not appropriately controlled. The compound's promotion of cell migration and proliferation is relevant in any assay where these parameters are unintended confounders. This material is provided for research purposes only.